{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1678636940",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/944754984"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/713946165",
    "http://id.who.int/icd/release/11/2024-01/mms/316694644",
    "http://id.who.int/icd/release/11/2024-01/mms/811840017",
    "http://id.who.int/icd/release/11/2024-01/mms/133206895",
    "http://id.who.int/icd/release/11/2024-01/mms/1678636940/other",
    "http://id.who.int/icd/release/11/2024-01/mms/1678636940/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1678636940",
  "code": "2B32",
  "source": "http://id.who.int/icd/entity/1678636940",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/1678636940/postcoordinationScale/histopathology",
      "axisName": "http://id.who.int/icd/schema/histopathology",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1408349555",
        "http://id.who.int/icd/release/11/2024-01/mms/908728518"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/1678636940/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Immunodeficiency-associated lymphoproliferative disorders"
  },
  "definition": {
    "@language": "en",
    "@value": "Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV-negative lymphomas of predominantly B-cell or less often T-cell type. In other immunodeficiency-associated lymphoproliferative disorders, association with EBV is less pronounced."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "PTLD - [Post transplant lymphoproliferative disorder]"
      }
    }
  ]
}